Antituberculosis drug resistance in the south of Vietnam: Prevalence and trends

Journal of Infectious Diseases

Volumn 194, Issue 9, 2006, Pages 1226-1232

  Huong, Nguyen T ^a,e   Lan, Nguyen T N ^b   Cobelens, Frank G J ^c,e   Duong, Bui D ^a   Co, Nguyen V ^a   Bosman, Maarten C ^f   Kim, Sang Jae ^g   Van Soolingen, Dick ^d   Borgdorff, Martien W ^c,e  

^a National Hospital of Tuberculosis and Respiratory Diseases   (Viet Nam)

^b Pham Ngoc Thach Hospital   (Viet Nam)

^c KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; CONCENTRATION (PARAMETERS); DISEASE PREDISPOSITION; DISEASE TRANSMISSION; FEMALE; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; SHORT COURSE THERAPY; SPUTUM ANALYSIS; SPUTUM SMEAR; TUBERCULOSIS; VIET NAM;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; DATA COLLECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RISK FACTORS; RURAL POPULATION; TUBERCULOSIS; URBAN POPULATION; VIETNAM;

EID: 33750335073     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/507906     Document Type: Article

References (24)

1. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163:1009-21.
2. WHO Global Tuberculosis Programme. An expanded DOTS framework for effective tuberculosis control. WHO/CDS/TB/2002.297. Geneva: World Health Organization, 2002.
3. Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002; 185:1197-202.
4. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world: third global report. Geneva: World Health Organization, 2004.
5. Espinal MA. The global situation of MDR-TB. Tuberculosis (Edinb) 2003; 83:44-51.
6. WHO Global Tuberculosis Programme. Global tuberculosis control: surveillance, planning, financing. Geneva: World Health Organization, 2005.
7. Mukherjee JS, Rich ML, Socci AR, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004; 363:474-81.
8. Espinal MA, Dye C. Can DOTS control multidrug-resistant tuberculosis? Lancet 2005; 365:1206-9.
9. DeRiemer K, Garcia-Garcia L, Bobadilla-del-Valle M, et al. Does DOTS work in populations with drug-resistant tuberculosis? Lancet 2005; 365:1239-45.
10. Nelson LJ, Talbot EA, Mwasekaga MJ, et al. Antituberculosis drug resistance and anonymous HIV surveillance in tuberculosis patients in Botswana, 2002. Lancet 2005; 366:438-9.
11. Huong NT, Duong BD, Co NV, et al. Establishment and development of the National Tuberculosis Control Programme in Vietnam. Int J Tuberc Lung Dis 2005; 9:151-6.
12. Espinal MA. Time to abandon the standard retreatment regimen with first-line drugs for failures of standard treatment. Int J Tuberc Lung Dis 2003; 7:607-8.
13. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world: first global report. Geneva: World Health Organization, 1997.
14. Quy HT, Lan NT, Borgdorff MW, et al. Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? Int J Tuberc Lung Dis 2003; 7:631-6.
15. Quy HT, Cobelens FGJ, Lan NTN, Buu NT, Lambregts CSB, Borgdorff MW. Treatment outcomes by drug resistance, HIV-status and treatment regimen among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2006; 10:45-51.
16. Lönnroth K. Public health in private hands-studies on private and public tuberculosis care in Ho Chi Minh City, Vietnam [academic thesis]. Göteborg, Sweden: Göteborg University, 2000.
17. Lönnroth K, Thuong LM, Lambregts K, Quy HT, Diwan VK. Private tuberculosis care provision associated with poor treatment outcome: comparative study of semi-private lung clinic and the NTP in two urban districts in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2003; 7:165-71.
18. Quy HT, Lonnroth K, Lan NT, Buu TN. Treatment results among tuberculosis patients treated by private lung specialists involved in a public-private mix project in Vietnam. Int J Tuberc Lung Dis 2003; 7:1139-46.
19. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 2nd ed. Geneva: World Health Organization, 2003.
20. Royall RM. Model robust confidence intervals using maximum likelihood estimators. Int Stat Rev 1986; 54:221-6.
21. Rao JN, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics 1992; 48:577-85.
22. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 1989.
23. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86:420-8.
24. Anh DD, Borgdorff MW, Van LN, et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 2000; 6:302-5.